ACL is looking good today. This is one I want to pick early next year, closer to results to get the jump for ST trading. Might run early or longer; sometimes it's hard to fit in the ST timeframe.
ACL - Alchemia - cancer biotech.
"Alchemia is a drug discovery and development company with an FDA approved drug (fondaparinux), a late stage oncology product pipeline (Phase II and III) within its wholly owned subsidiary, Audeo Oncology, Inc. (Audeo), and a proprietary drug discovery platform, VAST."
Recently some publicity in biotech blogs 5 & 12 and also on tv (there's a link in #12). Phase III trials results due early next year.
Here's a link to the blog and you can easily find the references to ACL through search or the index. http://ozbiobuzz.blogspot.com.au/
